Search Results - "RICCIERI, V"

Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group by Avouac, J, Fransen, J, Walker, U A, Riccieri, V, Smith, V, Muller, C, Miniati, I, Tarner, I H, Randone, S Bellando, Cutolo, M, Allanore, Y, Distler, O, Valentini, G, Czirjak, L, Müller-Ladner, U, Furst, D E, Tyndall, A, Matucci-Cerinic, M

“…To identify a core set of preliminary items considered as important for the very early diagnosis of systemic sclerosis (SSc). A list of items provided by…”
Get more information

PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors by Garufi, C., Mancuso, S., Ceccarelli, F., Caruso, L., Alessandri, C., Di Franco, M., Priori, R., Riccieri, V., Scrivo, R., Truglia, S., Conti, F., Spinelli, F.R.

“…Objective. Patients Acceptable Symptom State (PASS) is a single dichotomized question assessing health satisfaction. We aimed to investigate PASS achievement…”
Get full text

CT evaluation of interstitial lung disease related to systemic sclerosis: visual versus automated assessment. A systematic review by Landini, N., Mattone, M., De Nardo, C., Ottaviani, F., Mohammad Reza Beigi, D., Riccieri, V., Orlandi, M., Cipollari, S., Catalano, C., Panebianco, V.

“…To identify similarities and differences between visual (VA) and automated assessment (AA) of systemic sclerosis-related interstitial lung disease (SSc-ILD) at…”
Get full text

Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort by Molteni, E, Pirone, C, Ceccarelli, F, Castellani, C, Alessandri, C, Di Franco, M, Riccieri, V, Spinelli, F R, Priori, R, Scrivo, R, Conti, F

“…Data from trials demonstrated that abatacept (ABA) has a good safety and efficacy profile in treating rheumatoid arthritis. We have studied the retention rate…”
Get full text

Nailfold capillaroscopy in the rheumatological current clinical practice in Italy: results of a national survey by Ingegnoli, F, Cornalba, M, De Angelis, R, Guiducci, S, Giuggioli, D, Pizzorni, C, Riccieri, V, Sebastiani, M, Sulli, A, Cutolo, M

“…This cross-sectional online study was designed by the study group on Capillaroscopy and Microcirculation in Rheumatic Diseases (CAP) of the Italian Society of…”
Get full text

Distribution of interleukin‐10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation by Scrivo, R., Conigliaro, P., Riccieri, V., Di Franco, M., Alessandri, C., Spadaro, A., Perricone, R., Valesini, G.

“…Summary Evidence exists that interleukin (IL)‐10 family cytokines may be involved in the pathogenesis of rheumatoid arthritis (RA). We sought to determine…”
Get full text

Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patients by Ceccarelli, F., Orrù, G., Pilloni, A., Bartosiewicz, I., Perricone, C., Martino, E., Lucchetti, R., Fais, S., Vomero, M., Olivieri, M., di Franco, M., Priori, R., Riccieri, V., Scrivo, R., Shoenfeld, Y., Alessandri, C., Conti, F., Polimeni, A., Valesini, G.

“…Summary Several studies have suggested a link between human microbiome and rheumatoid arthritis (RA) development. Porphyromonas gingivalis seems involved in RA…”
Get full text

Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus by Lande, R., Palazzo, R., Gestermann, N., Jandus, C., Falchi, M., Spadaro, F., Riccieri, V., James, E. A., Butera, A., Boirivant, M., Feldmeyer, L., Surbeck, I., Di Lucca, J., Stuber, F., Spinelli, F. R., Botti, E., Marinari, B., Bianchi, L., Pica, R., Cerbelli, B., Giannakakis, K., Auteri, S. E., Daniels, I., Durrant, L. G., Horstman, S., Costanzo, A., Romero, P., Alessandri, C., Conti, F., Valesini, G., Gilliet, M., Chizzolini, C., Frasca, L.

“…LL37 exerts a dual pathogenic role in psoriasis. Bound to self-DNA/RNA, LL37 licenses autoreactivity by stimulating plasmacytoid dendritic cells-(pDCs)-Type I…”
Get full text

Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis by Allanore, Y, Meune, C, Vonk, M C, Airo, P, Hachulla, E, Caramaschi, P, Riemekasten, G, Cozzi, F, Beretta, L, Derk, C T, Komócsi, A, Farge, D, Balbir, A, Riccieri, V, Distler, O, Chialà, A, Del Papa, N, Simic, K Pasalic, Ghio, M, Stamenkovic, B, Rednic, S, Host, N, Pellerito, R, Zegers, E, Kahan, A, Walker, U A, Matucci-Cerinic, M

“…To measure the prevalence of, and factors associated with, left ventricular (LV) dysfunction in systemic sclerosis (SSc). The EUSTAR database was first…”
Get more information

NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis by Dieudé, P, Guedj, M, Wipff, J, Ruiz, B, Riemekasten, G, Airo, P, Melchers, I, Hachulla, E, Cerinic, M Matucci, Diot, E, Hunzelmann, N, Caramaschi, P, Sibilia, J, Tiev, K, Mouthon, L, Riccieri, V, Cracowski, J L, Carpentier, P H, Distler, J, Amoura, Z, Tarner, I, Avouac, J, Meyer, O, Kahan, A, Boileau, C, Allanore, Y

“…Recent evidence has highlighted a potential role of interleukin 1β (IL-1β) in systemic sclerosis (SSc). NLRP1 provides a scaffold for the assembly of the…”
Get more information

Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population by Dieudé, P, Guedj, M, Wipff, J, Ruiz, B, Riemekasten, G, Matucci-Cerinic, M, Melchers, I, Hachulla, E, Airo, P, Diot, E, Hunzelmann, N, Cabane, J, Mouthon, L, Cracowski, J L, Riccieri, V, Distler, J, Meyer, O, Kahan, A, Boileau, C, Allanore, Y

“…TNFAIP3 encodes the ubiquitin-modifying enzyme, a key regulator of inflammatory signalling pathways. Convincing associations between TNFAIP3 variants and…”
Get more information

Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres by Fransen, J, Popa-Diaconu, D, Hesselstrand, R, Carreira, P, Valentini, G, Beretta, L, Airo, P, Inanc, M, Ullman, S, Balbir-Gurman, A, Sierakowski, S, Allanore, Y, Czirjak, L, Riccieri, V, Giacomelli, R, Gabrielli, A, Riemekasten, G, Matucci-Cerinic, M, Farge, D, Hunzelmann, N, Van den Hoogen, F H J, Vonk, M C

“…Systemic sclerosis (SSc) is associated with a significant reduction in life expectancy. A simple prognostic model to predict 5-year survival in SSc was…”
Get more information

Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study by Ruffatti, A, Del Ross, T, Ciprian, M, Nuzzo, M, Rampudda, M, Bertero, M T, Bergia, R, Caramaschi, P, Biasi, D, Capsoni, F, Montaguti, L, Ruffini, R, Brucato, A, Picillo, U, Fanelli, V, Riccieri, V, Piccoli, A, Valesini, G, Doria, A, Meroni, P L, Tincani, A

“…To asses risk factors for a first thrombotic event in antiphospholipid antibody (aPL) positive carriers and evaluate the efficacy of prophylactic treatments…”
Get more information

High prevalence of capillary abnormalities in patients with diabetes and association with retinopathy by Barchetta, I., Riccieri, V., Vasile, M., Stefanantoni, K., Comberiati, P., Taverniti, L., Cavallo, M. G.

“…Diabet. Med. 28, 1039–1044 (2011) Aims  To investigate the presence of capillary abnormalities in patients with Type 1 and Type 2 diabetes using nailfold…”
Get full text

Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: Association with the functional IRAK1 196Phe/532Ser haplotype by Dieudé, P., Bouaziz, M., Guedj, M., Riemekasten, G., Airò, P., Müller, M., Cusi, D., Matucci‐Cerinic, M., Melchers, I., Koenig, W., Salvi, E., Wichmann, H. E., Cuomo, G., Hachulla, E., Diot, E., Hunzelmann, N., Caramaschi, P., Mouthon, L., Riccieri, V., Distler, J., Tarner, I., Avouac, J., Meyer, O., Kahan, A., Chiocchia, G., Boileau, C., Allanore, Y.

“…Objective Several autoimmune disorders, including systemic sclerosis (SSc), are characterized by a strong sex bias. To date, it is not known whether genes on…”
Get full text

Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor by Alessandri, C, Bartosiewicz, I, Pendolino, M, Mancini, R, Colasanti, T, Pecani, A, Morello, F, Mastrangelo, A, Sabatinelli, D, Riccieri, V, Di Franco, M, Ceccarelli, F, Perricone, C, Conti, F, Valesini, G

“…To investigate the prevalence of anti-carbamylated protein antibodies (anti-CarP) in the healthy first-degree relatives (HFDRs) of patients with rheumatoid…”
Get full text

Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension by Stefanantoni, K, Sciarra, I, Vasile, M, Badagliacca, R, Poscia, R, Pendolino, M, Alessandri, C, Vizza, C D, Valesini, G, Riccieri, V

“…Pulmonary arterial hypertension (PAH) can be idiopathic or secondary to autoimmune diseases, and it represents one of the most threatening complications of…”
Get full text

Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study by GHIRARDELLO, A, VILLALTA, D, RADICE, A, RICCIERI, V, RUFFATTI, A, SEBASTIANI, G. D, SINICO, R. A, TINCANI, A, DORIA, A, MOROZZI, G, AFELTRA, A, GALEAZZI, M, GERLI, R, MATHIEU, A, MERONI, P. L, PREGNOLATO, F, MIGLIORINI, P

“…An Italian multicentre study was promoted in order to assess the accuracy of four anti-double-stranded DNA (dsDNA) antibody assays for SLE diagnosis and…”
Get full text

Autonomic dysfunction and neuropeptide Y in fibromyalgia by Di Franco, M, Iannuccelli, C, Alessandri, C, Paradiso, M, Riccieri, V, Libri, F, Valesini, G

“…Fibromyalgia (FM) is a syndrome associated with widespread pain and various other signs and symptoms. Several of these multisystem features could be explained…”
Get full text

Methotrexate effect on anti-cyclic citrullinated peptide antibody levels in rheumatoid arthritis by Spadaro, A, Riccieri, V

“…At baseline, the presence of anti-CCP antibodies does not seem to be a predictive factor of clinical and laboratory response, evaluated by American College of…”
Get full text